204 related articles for article (PubMed ID: 9022793)
1. Syntheses and structure-activity relationships of taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III.
Ojima I; Slater JC; Kuduk SD; Takeuchi CS; Gimi RH; Sun CM; Park YH; Pera P; Veith JM; Bernacki RJ
J Med Chem; 1997 Jan; 40(3):267-78. PubMed ID: 9022793
[TBL] [Abstract][Full Text] [Related]
2. Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells.
Ojima I; Slater JC; Michaud E; Kuduk SD; Bounaud PY; Vrignaud P; Bissery MC; Veith JM; Pera P; Bernacki RJ
J Med Chem; 1996 Sep; 39(20):3889-96. PubMed ID: 8831755
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of nonaromatic taxoids: effects of alkyl and alkenyl ester groups on cytotoxicity.
Ojima I; Kuduk SD; Pera P; Veith JM; Bernacki RJ
J Med Chem; 1997 Jan; 40(3):279-85. PubMed ID: 9022794
[TBL] [Abstract][Full Text] [Related]
4. Syntheses and biological activity of C-3'-difluoromethyl-taxoids.
Ojima I; Lin S; Slater JC; Wang T; Pera P; Bernacki RJ; Ferlini C; Scambia G
Bioorg Med Chem; 2000 Jul; 8(7):1619-28. PubMed ID: 10976509
[TBL] [Abstract][Full Text] [Related]
5. Chemistry and chemical biology of taxane anticancer agents.
Miller ML; Ojima I
Chem Rec; 2001; 1(3):195-211. PubMed ID: 11895119
[TBL] [Abstract][Full Text] [Related]
6. [Studies on structure modification and structure-activity relationship of new taxoids derived from sinenxan a].
Huang G; Guo J; Liang X
Yao Xue Xue Bao; 1998 Aug; 33(8):576-86. PubMed ID: 12016896
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of novel 2',2'-difluoro analogues of docetaxel.
Uoto K; Ohsuki S; Takenoshita H; Ishiyama T; Iimura S; Hirota Y; Mitsui I; Terasawa H; Soga T
Chem Pharm Bull (Tokyo); 1997 Nov; 45(11):1793-804. PubMed ID: 9396156
[TBL] [Abstract][Full Text] [Related]
8. Anti-proliferative activity of a new class of taxanes (14beta-hydroxy-10-deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells.
Distefano M; Scambia G; Ferlini C; Gaggini C; De Vincenzo R; Riva A; Bombardelli E; Ojima I; Fattorossi A; Panici PB; Mancuso S
Int J Cancer; 1997 Sep; 72(5):844-50. PubMed ID: 9311603
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of new antitumor taxoids. Effects of cyclohexyl substitution at the C-3' and/or C-2 of taxotere (docetaxel).
Ojima I; Duclos O; Zucco M; Bissery MC; Combeau C; Vrignaud P; Riou JF; Lavelle F
J Med Chem; 1994 Aug; 37(16):2602-8. PubMed ID: 7914541
[TBL] [Abstract][Full Text] [Related]
10. Semi-synthesis of an O-glycosylated docetaxel analogue.
Nikolakakis A; Haidara K; Sauriol F; Mamer O; Zamir LO
Bioorg Med Chem; 2003 Apr; 11(7):1551-6. PubMed ID: 12628678
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxicity of 2alpha-amido docetaxel analogues.
Fang WS; Liu Y; Liu HY; Xu SF; Wang L; Fang QC
Bioorg Med Chem Lett; 2002 Jun; 12(11):1543-6. PubMed ID: 12031338
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, modeling, and anti-tubulin activity of a D-seco paclitaxel analogue.
Barboni L; Giarlo G; Ricciutelli M; Ballini R; Georg GI; VanderVelde DG; Himes RH; Wang M; Lakdawala A; Snyder JP
Org Lett; 2004 Feb; 6(4):461-4. PubMed ID: 14961598
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.
Miller ML; Roller EE; Zhao RY; Leece BA; Ab O; Baloglu E; Goldmacher VS; Chari RV
J Med Chem; 2004 Sep; 47(20):4802-5. PubMed ID: 15369381
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of taxoids 5. Synthesis and evaluation of novel water-soluble prodrugs of a 3'-desphenyl-3'-cyclopropyl analogue of docetaxel.
Yamaguchi T; Harada N; Ozaki K; Arakawa H; Oda K; Nakanishi N; Tsujihara K; Hashiyama T
Bioorg Med Chem Lett; 1999 Jun; 9(12):1639-44. PubMed ID: 10397492
[TBL] [Abstract][Full Text] [Related]
15. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance.
Ji X; Gao Y; Chen L; Zhang Z; Deng Y; Li Y
Int J Pharm; 2012 Jan; 422(1-2):390-7. PubMed ID: 22001531
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological activity of novel C2-C3' N-Linked macrocyclic taxoids.
Ojima I; Geng X; Lin S; Pera P; Bernacki RJ
Bioorg Med Chem Lett; 2002 Feb; 12(3):349-52. PubMed ID: 11814794
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 2'-methyl taxoids derived from baccatin III and 14beta-OH-baccatin III 1,14-carbonate.
Battaglia A; Bernacki RJ; Bertucci C; Bombardelli E; Cimitan S; Ferlini C; Fontana G; Guerrini A; Riva A
J Med Chem; 2003 Nov; 46(23):4822-5. PubMed ID: 14584931
[TBL] [Abstract][Full Text] [Related]
18. MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models.
Naito M; Matsuba Y; Sato S; Hirata H; Tsuruo T
Clin Cancer Res; 2002 Feb; 8(2):582-8. PubMed ID: 11839680
[TBL] [Abstract][Full Text] [Related]
19. Isolation, identification, semi-synthesis of aziditaxel derivatives and their biological evaluation.
Zhang SE; Tao JY; Zhao Y; Wang SR; Zhou D; Fang WS
J Asian Nat Prod Res; 2012; 14(5):463-75. PubMed ID: 22530674
[TBL] [Abstract][Full Text] [Related]
20. Novel cytotoxic 3'-(tert-butyl) 3'-dephenyl analogs of paclitaxel and docetaxel.
Ali SM; Hoemann MZ; Aubé J; Mitscher LA; Georg GI; McCall R; Jayasinghe LR
J Med Chem; 1995 Sep; 38(19):3821-8. PubMed ID: 7562913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
